Guideline adherence for the treatment of advanced schistosomiasis japonica in Hubei, China by Fangying Zhong et al.
ORIGINAL PAPER
Guideline adherence for the treatment of advanced
schistosomiasis japonica in Hubei, China
Fangying Zhong & Chenxi Liu & Xinping Zhang
Received: 27 August 2014 /Accepted: 23 September 2014 /Published online: 2 October 2014
# The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract This study compared physicians’ practices on three
treatment procedures and hospitalization days with guideline
recommendations to assess guideline adherence in the treat-
ment of advanced schistosomiasis japonica. Descriptive sta-
tistics were used to estimate patients’ characteristics and rate
of guideline adherence. And chi-square tests were used to
assess influences of severity of the disease on guideline ad-
herence. The study found no one (0/173) adhered to adequate
diagnosis, treatment regimens, and discharge criteria of guide-
lines completely. And 2.23 % of patients in group 1 and
4.23 % in group 2 were totally conforming to adequate diag-
nosis. 91.91 % of patients were conforming to adequate
treatment regimens among which group 1 and group 2 were
90.32 and 92.25 %, respectively. And one (2.23 %) patient in
group 1 and zero (0 %) in group 2 were conforming to
discharge criteria of guidelines, and most of the patients left
hospital without symptom checks (151/173), liver function
and biochemical tests (169/173), and complication checks
(91/173). Among 173 inpatients, rate of adequate hospitaliza-
tion days was 36.42 % (63/173). And chi-square test sug-
gested no significant difference (P>0.05) on guideline adher-
ence in two groups, which implied both of critical and general
patients’ treatments should be stressed to comply with guide-
lines. There existed a large gap between guidelines and prac-
tices of the treatment of advanced schistosomiasis japonica.
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Introduction
Clinical practice guidelines have proliferated in recent decades
as an attempt to improve the effectiveness and efficiency of
health care (McCormack and Loewen 2007). Emphasis on the
development and implementation of guidelines has been
fueled by research documenting high rates of inappropriate
care and wide variations in clinical practice for common
health care conditions (McGlynn et al. 2003; Bampton et al.
2007). Adherence to clinical practice guidelines is advocated
as a method to decrease utilization of ineffective therapies and
increase adoption of evidence-based practices, ultimately
resulting in improved patient outcomes and more cost-
effective care. Belief in the ability of guidelines to improve
quality of care has led to a rapid proliferation in the number of
guidelines available for a wide variety of clinical conditions
(Larson 2003; Walter et al. 2009; Moonen and Cohe 2011).
Although the primary goal of clinical practice guidelines is to
improve quality, few of researches have actually examined the
impact of adherence to guideline recommendations on clinical
diagnosis, treatment regimens, and discharge criteria (Fritz
et al. 2007).
Schistosomiasis affects about 74 countries and regions
containing 200 million people worldwide, and more than
650 million people live in endemic areas. Several million
people all over the world suffer from severe morbidity as a
consequence of schistosomiasis. Its infections impose a great
burden on poor populations in the developing world (WHO
2006). China is an endemic area of schistosoma japonica and
one of the four countries most seriously harmed by schistoso-
miasis in the globe (Ren 2009; Zhu et al. 2010). Much billion
Yuan was expended to control the disease, with themajority of
costs related to prevention as well as prescription medication.
Like other common conditions, inappropriate variations in
care and unacceptably high use of ineffective therapies might
lead to serious organic injury or complication such as upper
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gastrointestinal bleeding (UGB) (Chen 2002). All of the above
calls for increased adherence to clinical practice guidelines of
schistosomiasis.
Although all patients with schistosomiasis seek care and
receive therapy in the local lazaret or the designated hospital
and they are managed in local Center for Disease Control and
Prevention (CDC), there still exists incorrect and unreliable
diagnosis, etc. (Feng et al. 2011). Because of serious conse-
quence of schistosomiasis, many clinical practice guidelines
have been developed to direct primary care providers towards
more evidence-basedmanagement (Lugtenberg 2011). Guide-
lines provide a series of active criteria for clinical diagnosis
and treatment regimens so that passive treatment could be
minimized (Hope et al. 2008). Therefore, adherence to guide-
lines by clinicians managing patients with schistosomiasis has
been of great concern.
The principle of diagnosis and treatment guideline is
accordant with most patients, so guideline adherence
should be promoted (Shao 2012; Fenwick et al. 2009).
However, study exploring the adherence to guideline
recommendations of schistosomiasis is lacking. Most
researches have examined the impact of adherence on
costs and process-related variables (Cretin et al. 2007).
The study took clinical diagnosis, treatment regimens,
and discharge criteria into consideration and analyzed
the targets in relation to guideline adherence. And our
study, by presetting a research hypothesis, devoted that
there was approving guideline adherence in the treatment
of patients with advanced schistosomiasis. The main
purpose of this study was to examine adherence to the
guideline recommendations for the practice provided by
physicians to patients with advanced schistosomiasis and
finally to promote rational and adequate schistosomiasis
care.
Methods
The criteria for evaluating guideline adherence
Guidelines for the study reference are the Ministry of Health
of the People’s Republic of China (Diagnostic Criteria for
Schistosomiasis) and Disease Prevention and Control Depart-
ment of the Ministry of Health of the People’s Republic of
China (Schistosomiasis Control Manual (the third edition)).
On the basis of the guidelines above, a criteria was formulated
for the adherence study as shown in Table 1 (Schwentner et al.
2013). The criteria contained guideline recommendations of
three treatment procedures, which were diagnosis, treatment
regimens, and discharge check, respectively. According
to the criteria, we did a comparative analysis with the
actual treatment for patients with advanced schistosomi-
asis japonica.
Study population
A retrospective study of patients with advanced schistosomi-
asis japonica was conducted from July 2013 to February 2014.
Patients with advanced schistosomiasis at two Chinese repre-
sentative hospitals including Gong’an Schistosomiasis Spe-
cial Hospital and Shishou Third People’s Hospital were in-
cluded in the study and eligible if they (1) were not seriously
ill or without any other disorder; (2) do not have serious
schistosomiasis complications and organic diseases, hepatitis,
or any other liver dysfunction; (3) were over 4 years of age
(WHO 2006); (4) were without history of adverse drug reac-
tions; and (5) have complete medical records.
Data collection
One hundred seventy-three patients’ general characteristics,
which contained sex, age, state of health, job, and history of
disease, were recorded at admission from January 2010 to
November 2013. We would assess the guideline adherence in
the treatment for patients with advanced schistosomiasis ja-
ponica. So, the related diagnosis, treatment regimens, and
discharge check of these patients were collected by rule and
line.
Because the severity of disease was one of the most im-
portant factors which influenced the practices of physicians’
diagnosis and treatment behavior (Chen 2007; Ma and Zhong
2004), the study divided the 173 patients into two groups.
Group 1 comprises 31 critical patients, and group 2 comprises
142 general patients according to severity of advanced schis-
tosomiasis japonica.
Statistical analysis
Descriptive statistics were used to estimate patients’ charac-
teristics in the study population and to compare the two groups
according to their characteristics concordance status. To fur-
ther elucidate the impact of guideline adherence, we calculat-
ed the rate of adequate diagnosis, treatment regimens, and
discharge check, respectively, and the total rate of all the three
procedures conforming to guideline recommendations as seen
in the following formulas. Then, for the above three proce-
dures, chi-square tests were used to assess differences between
the two groups, when appropriate. All tests were bilateral, and
a P value of <0.05 was considered statistically significant.
Statistical analyses were performed using Statistical Package
for the Social Sciences (SPSS) 13.0. Finally, through compar-
ative analysis, guideline adherence would be stated
clearly. Rate of adequateA  ¼ Total number of adequate
A  =Total number of A  100 % A representeddiagnosis;ð
treatment regimens; and discharge check; respectively:Þ
Total rate ¼ Total number of all the three procedures
conforming toguidelines=Total number in the study100%
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Results
General characteristics
A total of 173 patients with advanced schistosomiasis japon-
ica were studied, 106 of whom were males. Thirty-one pa-
tients were included in group 1, and the others were in group 2
(Table 2). There was no statistical significance in terms of sex,
age, state of health, job, and history of disease of the patients
between group 1 and group 2. Thus, all of the above analysis
demonstrated that there was good comparability in the two
groups.
Overall guideline adherence
The study found that only one (2.23 %) patient in group 1 was
totally in accordance with adequate diagnosis or discharge
criteria. And 28 (90.32 %) patients’ treatment regimens were
adequate in the group. Besides, there were 6 (4.23 %),
131 (92.25 %), and 0 (0 %) patients, respectively, that
conform to adequate diagnosis, treatment regimens, and
discharge criteria. What is more, no one (0/173) was
conforming to adequate diagnosis, treatment regimens, and
discharge criteria according to guidelines at the same time
(Table 3).
Adherence of diagnosis
Table 4 showed the distribution of four diagnosis practices
according to guidelines in the two groups. The rate of ade-
quate recommendation to check history of infected water
contact was the highest, which of two groups were 96.77
and 95.77 %, separately. Physicians’ compliance with
Table 1 The criteria for evaluating guideline adherence based on Diagnostic Criteria for Schistosomiasis and Schistosomiasis Control Manual (the third
edition)
Conforming to guideline Nonconforming to guideline
Diagnosis
History of infected water contact Duration of contact with infected water or prior
schistosomiasis treatment
Neither duration of contact with infected water
nor prior schistosomiasis treatment
Clinical manifestations Portal hypertension, dwarf or colonic granuloma Without portal hypertension, dwarf and
colonic granuloma
Etiological examination Find worm eggs or miracidium Never find worm eggs or miracidium
Immunologic test Patients without history of schistosomiasis treatment
or with more than 2 years of treatment: IHA≥1:10,
one or more of ELISA, DIGFA, and DDIAwere
positive
Patients without history of schistosomiasis treatment
or with more than 2 years of treatment: IHA<1:10,
all of ELISA, DIGFA, and DDIAwere negative
Treatment regimens
No praziquantel therapy Taking Non-taking
Liver-protecting therapy Taking hepatinica Not taking hepatinica
Symptomatic therapy Done Not done
Discharge criteria, hospitalization days
Patient’s state on discharge Vital signs turning normal Vital signs not turning normal
Symptom check No fever, no abdominal pain, etc. Fever, abdominal pain, etc.
Liver function and biochemical test Turning normal Not turning normal
Complications No severe complications Severe complications
Hospitalization days 10~15 days <10 or >15 days
Table 2 The characteristics of the study groups based on 31 critical
patients and 142 general patients with advanced schistosomiasis japonica
included in the study
Group 1 Group 2 χ2 P value
Sex Male 15 91 2.642 0.104 P
Female 16 51
Age 40≤ 0 13 5.388 0.068 P
40–60 12 69
≥60 19 60
State of health Good 2 9 0.089 0.956 P
General 24 113
Poor 5 20
Job Farmer 30 140 0.428 0.681 F
Else 1 2
History of disease No 0 15 3.586 0.058 P
Yes 31 127
F Fisher’s exact test, P Pearson’s chi-square test
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diagnosis recommendations for clinical manifestation check
and etiological examination was on the low side. As for
immunologic test, the study found the rate is 70.97 % in group
1 and 65.49 % in group 2. Finally, the chi-square test sug-
gested there was no significant difference (P>0.05) on guide-
line adherence of the four diagnoses in the two groups.
Adherence of treatment regimens
Through statistics, there was a high rate of adequate treatment
regimens. In group 1, 100 % treatment regimens of liver-
protecting therapy and no praziquantel therapy were
conforming to guidelines, and 28 (90.32 %) regimens of
symptomatic therapy complied with the guidelines. As for
group 2, the rate of three treatment regimens in accordance
with guidelines was 99.30, 100, and 92.96 %, respectively.
Besides, the chi-square test showed there was no significant
difference (P=0.614) on symptomatic therapy in the two
groups (Table 5).
Adherence of discharge criteria and hospitalization days
Table 6 showed the compliance with guidelines to check
patient’s state on discharge was good, as the rate was 96.77
and 97.89 % in the two groups. In contrast, the rate of
adequate symptom check and liver function and biochemical
test was low. Discharge checks of 13 (41.94 %) patients in
group 1 and 69 (48.59 %) in group 2 were conforming to
guidelines to check complications. Besides, the chi-square test
showed there was no significant difference (P>0.05) on
guideline adherence of the four discharge checks in the two
groups.
Among the 173 inpatients, the rate of adequate hospitali-
zation days was 36.42 % (63/173). The other inpatients re-
ceived the hospitalization care more than 15 days or less than
10 days. The rate of group 1 and group 2 was 29.03 % (9/31)
and 38.03 % (54/142) separately, and there was no significant
difference (0.346) between the two through chi-square test.
Discussion
Guideline recommendations may be based on either scientific
evidence or the expertise of the guideline developers via a
consensus decision-making process (Marciano et al. 2014). In
order to cure patients with advanced schistosomiasis japonica
better, authorized guidelines should be adhered by physicians
to standardize treatment procedures. The primary objective of
this study was to assess concordance based on the guideline
recommendations for the practice provided by physicians to
patients with advanced schistosomiasis.
The study found that no one (0/173) adhered to adequate
diagnosis, treatment regimens, and discharge criteria accord-
ing to guidelines at the same time. And only 2.23% patients in
group 1 and 4.23 % ones in group 2 were totally conforming
to adequate diagnosis. However, the above nonstandard be-
haviors of diagnosis practice would be reasons for misdiag-
nosis (Chen 2007). Previous researches had found that misdi-
agnosis could and did occur and was reasonably commonwith
error rates ranging from 1.4% to a high 20–40%misdiagnosis
rate, and surveys of patients also indicated the chance of
experiencing a misdiagnosis to range from 8 to 40 % (Right
Diagnosis 2014; Reed and May 2011). Besides, a high
Table 3 The rate of adequate procedure according to guidelines
Adequate procedure Group 1 Ratea (%) Group 2 Rate (%) Total rate (%)
Diagnosis 1 2.23 6 4.23 0 (0/173)
Treatment regimens 28 90.32 131 92.25
Discharge criteria 1 2.23 0 0
a Rate represents the rate of adequate procedure
Table 4 Guideline adherence of
diagnosis recommendations Group 1 Rate (%) Group 2 Rate (%) χ
2 P value
History of infected water contact Yes 30 96.77 136 95.77 0.065 0.798
No 1 6
Clinical manifestations Yes 6 19.35 28 19.72 0.002 0.963
No 25 114
Etiological examination Yes 11 35.48 42 29.58 0.418 0.518
No 20 100
Immunologic test Yes 22 70.97 93 65.49 0.342 0.559
No 9 49
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misdiagnosis rate of schistosomiasis was shown in China
because of nonstandard diagnosis procedures (Wu and Huang
2006; Zhu et al. 2010). There were various reasons as to why a
misdiagnosis could occur including errors by physicians. For
example, physicians in non-endemic areas were usually unfa-
miliar with schistosomiasis (Nguyen et al. 2012), and hence,
misdiagnosis might occur (Huang andManderson 2005). There-
fore, it was very necessary for physicians to conform to guide-
lines to diagnose patients with advanced schistosomiasis japon-
ica. In the study, physicians’ compliance with diagnosis recom-
mendations for clinical manifestation check and etiological ex-
amination was especially on the low side so that the two
diagnosis recommendations should be conformed emphatically.
In the study, there were totally 91.91 % of adequate treat-
ment regimens. And just 13 (7.51 %) regimens of taking
symptomatic therapy were not following guidelines, among
which there are 3 (3/31) in group 1 and 10 (10/142) in group 2.
Research reported that less than 40 % of patients in the public
sector and 30 % in the private sector are treated according to
clinical guidelines in developing countries (WHO 2010). And
these clinical practices might result from irrational drug use.
WHO once estimated that more than half of all medicines are
prescribed, dispensed, or sold inappropriately and that half of
all patients fail to take them correctly (WHO 2014; Fromer
and Cooper 2008). Medically inappropriate, ineffective, and
economically inefficient use of pharmaceuticals is commonly
observed in the health care system throughout the world
(Editorial 2012). Researches have shown that irrational treat-
ment could lead to praziquantel-resistant isolates of schisto-
somiasis (Wang et al. 2012; Cioli and Pica-Mattoccia 2003).
Hence, it is crucial to improve physicians’ compliance with
treatment regimen recommendations of guidelines, especially
in symptomatic therapy (Rumsfel 2011).
All patients with advanced schistosomiasis japonica re-
quired hospitalizations. If hospitalization days were not
enough, patients would underutilize adequate treatment. And
complete discharge checks would make sure whether patients
leave hospital appropriately. The study found that only one
(2.23 %) patient in group 1 and zero (0 %) in group 2 were in
accordance with discharge criteria of guidelines, and most of
the patients left hospital without symptom check (22/173),
liver function and biochemical tests (4/173), and complication
check (82/173). Among the 173 inpatients, the rate of ade-
quate hospitalization days was just 36.42% (63/173). Besides,
previous studies in China have shown that the discharge
checks and the hospitalization days were the main factors
influencing inpatients’ medical expenses and overuse (WHO
2010; Wang et al. 2009; Gurarie et al. 2010). Therefore,
following discharge criteria, especially in the above three
aspects of discharge check, and hospitalization of guideline
recommendations could effectively lead to rational drug use,
adequately treat diseases, and minimize medical service cost.
What is more, the chi-square test suggested that there was
no significant difference (P>0.05) on guideline adherence in
Table 5 Guideline adherence of treatment regimen recommendations
Group 1 Rate (%) Group 2 Rate (%) χ2 P value
No praziquantel therapy Yes 31 100 141 99.30 –a –
No 0 1
Liver-protecting therapy Yes 31 100 142 100 – –
No 0 0
Symptomatic therapy Yes 28 90.32 132 92.96 0.254 0.614
No 3 10
a The subjects’ distribution of no praziquantel therapy and liver-protecting therapy in two groups did not meet the criteria of chi-square test
Table 6 Guideline adherence of discharge criteria recommendations
Group 1 Rate (%) Group 2 Rate (%) χ2 P value
Patient’s state on discharge Yes 30 96.77 139 97.89 0.14 0.550 F
No 1 3
Symptom check Yes 4 12.90 18 12.77 0.001 0.973
No 27 124
Liver function and biochemical test Yes 0 0 4 2.82 0.894 0.344 F
No 31 138
Complications Yes 13 41.94 69 48.59 0.452 0.501
No 18 73
F Fisher’s exact test
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the two groups in the study. The severity of advanced schisto-
somiasis japonica could not influence physicians’ practices to
adhere to guidelines. Thus, both of critical and general pa-
tients’ treatments should be stressed to comply with guidelines.
To our knowledge, this is the first study to evaluate guide-
line adherence in the treatment for patients with advanced
schistosomiasis japonica in the two groups’ clinical practices.
Strengths of the study include multiangle analysis of treatment
procedures and the disease severity and some important ap-
plication values for health sectors and policymakers. The
findings of the study are subject to some limitations. Because
of limited data, we did not study whether these guidelines
were adequate or valid for advanced schistosomiasis treat-
ment. Consequently, we assessed compliance based on the
guideline recommendations only and did not study the subject
in more depth (Richard-Tremblay et al. 2012).
Conclusions
The large gap between guidelines and the practices of treatment
for patients with advanced schistosomiasis japonica was found
in the study. Therefore, it is time for health sectors to take
measures to standardize physicians’ practice through guidelines.
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